Psoriasis Trial, Recruiting NCT07648602 Sponsor: CorEvitas Condition: Psoriasis
Back to Psoriasis

Psoriasis Trial, Recruiting

NCT07648602
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are at least 18 years old at the time of joining the study
  • People who have been diagnosed with moderate to severe plaque psoriasis, confirmed by a doctor's assessment at the time of enrollment (a specific score of 3 or 4 on a standard scale used by the investigating doctor)
  • People who are starting a specific qualifying medication for plaque psoriasis for the first time
  • People who are willing and able to give their written agreement to take part in the study

Who may not be able to join:

  • People who are currently taking part in a blinded clinical trial (a type of study where participants do not know which treatment they are receiving)
  • People who do not receive at least one dose of the study medication within 14 days after their enrollment and baseline visit
  • People who are already enrolled in the CorEvitas Psoriasis Registry — the trial site would not be able to enroll those individuals in this study at the same time (confirm with trial site)
  • People cannot be enrolled in both this study and the CorEvitas Psoriasis Registry at the same time; however, once a person has completed or exited this study, enrollment into the CorEvitas Psoriasis Registry for long-term follow-up may become available through the trial site, with a separate consent process (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +1 508 408 5433

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
CorEvitas
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
31 December 2036

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Creation of a cohort of psoriasis subjects

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov